Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hugh R Barrett

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 1, 2015
Lipoprotein Metabolism in APOB L343V Familial HypobetalipoproteinemiaAmanda J Hooper, Liesl Heeks, Ken Robertson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 31, 2015
Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitusEsther M Ooi, Gerald F Watts, Dick C Chan, et al.
Journal of Lipid Research|February 8, 2011
Plasma apolipoprotein C-III metabolism in patients with chronic kidney diseaseEsther M M Ooi, Doris T Chan, Gerald F Watts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2005
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol contentDawn E Telford, Sara M Lipson, P Hugh R Barrett, et al.
Journal of Lipid Research|July 10, 2012
Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjectsEsther M M Ooi, Alice H Lichtenstein, John S Millar, et al.
Atherosclerosis|October 19, 2004
Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosisKevin D O'Brien, Katherine Lewis, Jens W Fischer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2018
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (<i>LDLR</i><sup>+/-</sup> and <i>LDLR</i><sup>-/-</sup>) Yucatan Miniature PigsAmy C Burke, Dawn E Telford, Brian G Sutherland, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 27, 2021
Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose-response modelSatyawan B Jadhav, Ryan L Crass, Sunny Chapel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 29, 2015
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic StudyJan Borén, Gerald F Watts, Martin Adiels, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2011
Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutationsEsther M M Ooi, Betsy S Russell, Eric Olson, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|September 1, 2015
Lipoprotein Metabolism in APOB L343V Familial HypobetalipoproteinemiaAmanda J Hooper, Liesl Heeks, Ken Robertson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 31, 2015
Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitusEsther M Ooi, Gerald F Watts, Dick C Chan, et al.
Journal of Lipid Research|February 8, 2011
Plasma apolipoprotein C-III metabolism in patients with chronic kidney diseaseEsther M M Ooi, Doris T Chan, Gerald F Watts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2005
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol contentDawn E Telford, Sara M Lipson, P Hugh R Barrett, et al.
Journal of Lipid Research|July 10, 2012
Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjectsEsther M M Ooi, Alice H Lichtenstein, John S Millar, et al.
Atherosclerosis|October 19, 2004
Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosisKevin D O'Brien, Katherine Lewis, Jens W Fischer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2018
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (<i>LDLR</i><sup>+/-</sup> and <i>LDLR</i><sup>-/-</sup>) Yucatan Miniature PigsAmy C Burke, Dawn E Telford, Brian G Sutherland, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 27, 2021
Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose-response modelSatyawan B Jadhav, Ryan L Crass, Sunny Chapel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 29, 2015
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic StudyJan Borén, Gerald F Watts, Martin Adiels, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2011
Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutationsEsther M M Ooi, Betsy S Russell, Eric Olson, et al.
Pageof 15